iifl-logo

Panacea Biotec Ltd Half Yearly Results

346.35
(0.35%)
Nov 24, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Sept-2025Mar-2025Sept-2024Mar-2024Sept-2023

Gross Sales

307.83

296.02

263.07

286.96

272.21

Excise Duty

0

0

0

0

0

Net Sales

307.83

296.02

263.07

286.96

272.21

Other Operating Income

0

0

0

0

0

Other Income

26.09

42.69

13.96

22.01

39.82

Total Income

333.92

338.71

277.03

308.97

312.03

Total Expenditure

326.8

314.94

270.06

293.15

286.08

PBIDT

7.12

23.77

6.97

15.82

25.95

Interest

3

2.03

1.85

1.67

1.91

PBDT

4.12

21.74

5.12

14.15

24.04

Depreciation

16.73

17.4

17.41

17.92

18.79

Minority Interest Before NP

0

0

0

0

0

Tax

0.03

0.01

0

0.69

0

Deferred Tax

-2.59

1.88

-1.12

-0.27

2.56

Reported Profit After Tax

-10.05

2.45

-11.17

-4.19

2.69

Minority Interest After NP

-0.18

-0.35

0

-0.33

0

Net Profit after Minority Interest

-9.87

2.8

-11.17

-3.86

2.69

Extra-ordinary Items

13.99

30.48

5.51

5.52

27.95

Adjusted Profit After Extra-ordinary item

-23.86

-27.68

-16.68

-9.38

-25.26

EPS (Unit Curr.)

-1.62

0.46

-1.8

0

0.44

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

6.13

6.13

6.13

6.13

6.13

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

2.31

8.02

2.64

5.51

9.53

PBDTM(%)

-

-

-

-

-

PATM(%)

-3.26

0.82

-4.24

-1.46

0.98

Panacea Biotec: Related NEWS

Panacea Biotec Wins ₹127 Crore UNICEF Deal to Supply Polio Vaccines

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.

27 Dec 2024|05:23 PM
Read More
Panacea Biotec Shares Gain Amid Karnataka's Dengue Epidemic Declaration

Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.

4 Sep 2024|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.